{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-045569","form_type":"8-K","ticker":"RYTM","cik":"0001649904","company_name":"RHYTHM PHARMACEUTICALS, INC.","filed_at":"2026-06-25T20:46:19+00:00","discovered_at":"2026-06-25T20:47:00.290338+00:00","generated_at":"2026-06-25T20:47:10.250280+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Rhythm Pharmaceuticals stockholders elect two Class III directors, ratify auditor, approve say-on-pay","bullets":["David W.J. McGirr elected with 53.2M votes for, 8.7M withheld; David P. Meeker with 60.0M for, 1.9M withheld.","Ratification of Ernst & Young as FY2026 auditor approved: 63.9M for, 197.7K against, 23.6K abstained.","Advisory approval of named executive officer compensation: 50.4M for, 11.5M against, 36.7K abstained.","Total eligible votes 69.7M; 64.1M votes present (92% of eligible)."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-045569","json":"https://secwatch.observer/filing/0001628280-26-045569.json","markdown":"https://secwatch.observer/filing/0001628280-26-045569.md","text":"https://secwatch.observer/filing/0001628280-26-045569.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1649904/000162828026045569/0001628280-26-045569-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1649904/000162828026045569/rytm-20260624.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T20:47:10.250280+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}